Does AMINOLEVULINIC ACID Cause Application site vesicles? 21 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Application site vesicles have been filed in association with AMINOLEVULINIC ACID (AMELUZ). This represents 1.3% of all adverse event reports for AMINOLEVULINIC ACID.
21
Reports of Application site vesicles with AMINOLEVULINIC ACID
1.3%
of all AMINOLEVULINIC ACID reports
0
Deaths
1
Hospitalizations
How Dangerous Is Application site vesicles From AMINOLEVULINIC ACID?
Of the 21 reports, 1 (4.8%) required hospitalization.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMINOLEVULINIC ACID. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does AMINOLEVULINIC ACID Cause?
Drug ineffective (293)
Off label use (178)
Wrong technique in product usage process (173)
Erythema (144)
Product quality issue (132)
Poor quality product administered (124)
Pain (102)
Product dose omission issue (93)
Application site pain (90)
Application site erythema (81)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
Which AMINOLEVULINIC ACID Alternatives Have Lower Application site vesicles Risk?
AMINOLEVULINIC ACID vs AMINOPHYLLINE
AMINOLEVULINIC ACID vs AMINOSALICYLATE
AMINOLEVULINIC ACID vs AMINOSALICYLIC ACID
AMINOLEVULINIC ACID vs AMIODARONE
AMINOLEVULINIC ACID vs AMISULPRIDE